BSE Live
Mar 30, 16:00Prev. Close
0.48
Open Price
0.44
Bid Price (Qty.)
0.00 (0)
Offer Price (Qty.)
0.00 (0)
NSE Live
Dec 27, 11:22Prev. Close
-
Open Price
-
Bid Price (Qty.)
- (0)
Offer Price (Qty.)
- (0)
| Cash Flow of Hiran Orgochem (in Rs. Cr.) | Mar 15 | Mar 14 | Jun 13 | Jun 12 | Jun 11 | |
| 12 mths | 9 mths | 12 mths | 12 mths | 15 mths | ||
| Net Profit/Loss Before Extraordinary Items And Tax | -27.76 | -7.22 | -60.01 | -9.09 | -82.84 | |
| Net CashFlow From Operating Activities | -16.08 | -0.93 | -28.64 | 3.84 | -56.67 | |
| Net Cash Used In Investing Activities | 16.13 | 0.96 | 1.44 | 2.28 | -0.49 | |
| Net Cash Used From Financing Activities | 0.00 | 0.00 | -0.35 | -9.01 | 73.97 | |
| Foreign Exchange Gains / Losses | 0.00 | 0.00 | -0.32 | 5.75 | -0.61 | |
| Adjustments On Amalgamation Merger Demerger Others | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Inc/Dec In Cash And Cash Equivalents | 0.05 | 0.04 | -27.87 | 2.86 | 16.20 | |
| Cash And Cash Equivalents Begin of Year | 0.14 | 0.10 | 27.97 | 25.11 | 8.91 | |
| Cash And Cash Equivalents End Of Year | 0.18 | 0.14 | 0.10 | 27.97 | 25.11 |
17.06.2020
GDR manipulation case: SEBI slaps over Rs 61 crore fine on Hiran Orgochem, senior official, 2 others
02.06.2015
17.02.2015
18.02.2014
13.04.2026
13.04.2026
10.04.2026
09.04.2026
21.01.2026
Dr Reddy's posts smaller-than-expected Q3 profit fall on domestic boost
12.11.2025
07.11.2025
24.10.2025
Dr Reddy's Q2 Results: Net profit rises 7% to Rs 1,347 crore, misses estimates
17.07.2025
Sun Pharma Q1 PAT seen up 8.4% YoY to Rs 3,132.7 cr: ICICI Securities
17.07.2025
Biocon Q1 PAT may dip 72% YoY to Rs 91.1 cr: ICICI Securities
17.07.2025
Cipla Q1 PAT seen up 2% YoY to Rs 1,246.7 cr: ICICI Securities
29.01.2025
Sun Pharma Q3 Preview: Double-digit India, US sales to power mid-teen profit growth